期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 114, 期 27, 页码 7083-7088出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1620835114
关键词
regulatory T cells; transplantation; IL-2 therapy; calcineurin inhibitors; NFAT translocation
资金
- King's Health Partners Research Grant [R140807]
- Fundacio Marato TV3 Grant [287/C/2012]
- Medical Research Council [MR/L008890/1, MRK0255381]
- MRC [MR/P007694/1, MR/L008890/1] Funding Source: UKRI
- Medical Research Council [MR/J006742/1, MR/P007694/1, MR/L008890/1] Funding Source: researchfish
- National Institute for Health Research [ACF-2013-09-011] Funding Source: researchfish
CD4(+)CD25(+)FOXP3(+) Tregs constitute a heterogeneous lymphocyte subpopulation essential for curtailing effector T cells and establishing peripheral tolerance. Calcineurin inhibitors (CNIs) are among the most effective agents in controlling effector T-cell responses in humans. However, CNIs also reduce the size of the Treg pool. The functional consequences of this negative effect and the mechanisms responsible remain to be elucidated. We report here that CNIs compromise the overall Treg immunoregulatory capacity to a greater extent than would be predicted by the reduction in the size of the Treg compartment, given that they selectively promote the apoptosis of the resting and activated Treg subsets that are known to display the most powerful suppressive function. These effects are caused by reduced access to IL-2, because Tregs remain capable of translocating NFAT even in the presence of high CNI levels. Exogenous IL-2 restores the phenotypic changes and overall gene-expression effects exerted by CNIs and can even promote Treg expansion by enhancing antiapoptotic Bcl-2 expression. In a skin transplant model, the addition of IL-2 synergizes with CNIs treatment, promoting intragraft accumulation of Tregs and prolonged allograft survival. Hence, the combination of IL-2 and CNIs constitutes an optimal immunomodulatory regimen that enhances the pool of suppressive Treg subsets while effectively controlling cytopathic T cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据